NHS VIRTUAL WARDS

SAMD for Pharma

SAMD for Pharma

Deploy digital-first care with clinical confidence

Accelerate your transition to virtual wards and dramatically reduce your elective backlogs with a single platform solution.

Huma’s expertise in building and deploying virtual wards across multiple therapeutic areas has helped NHS Trusts around the country double clinical capacity1, reduce elective backlogs, and improve patient outcomes and experience. We understand patient and clinician needs, based on over a decade of experience and learnings from more than 450 deployments.

Improving clinical outcomes

90-95%

adherence and retention rates across our care and research deployments are the result of high engagement rates

x2

Our platform can almost double clinical capacity and reduce readmission rates by >30%

3-4x

lower mortality amongst Huma patients compared with patients not using Huma

88.2%

of patients highlighted as deteriorating had operation dates brought forward

FREE EBOOK

FREE EBOOK

FREE EBOOK

Download our complete guide on how to set-up a virtual ward

Our 21 page, essential guide to Virtual Wards, brings together Huma’s 10 years of experience in implementing remote patient monitoring and virtual wards in the NHS, with practical advice on deploying technology to alleviate NHS pressures.
Contents include:
  • How does a virtual ward work
  • How to set-up a virtual ward
  • Huma’s virtual ward technology
  • How we support patients and clinicians
  • Case studies
By adopting a digital-first approach, the study achieved high engagement, rapid recruitment, and increased medication adherence in patients with low baseline.
Read our whitepaper below to uncover the results of one of the first peer-reviewed assessments of a fully decentralized clinical trial:

Streamlining patient management

30%

Reduction in readmission rates

40%

Reduction in time spent reviewing patients

60%

Reduction in time calling patients compared to traditional telemedicine

19%

Reduction in outpatient appointments

BENEFITS

SAMD for Pharma

SAMD for Pharma

Safe. Effective. Efficient.

Huma virtual wards helps increase adherence to care plans and improve outcomes through continuous remote patient monitoring and engagement at scale. With a focus on patient safety, near real-time data collection and monitoring helps clinicians optimise patient outcomes by identifying issues sooner for more timely interventions.

Huma’s award-winning, intuitive, patient-centric design encourages easier patient adoption and adherence, with 99.7% of patients reporting they found the Huma app helpful.

FLEXIBLE. MODULAR. CONFIGURABLE.

SAMD for Pharma

SAMD for Pharma

Increase productivity. Reduce backlogs.

Double your clinical capacity1 and cut your elective backlog in half by treating patients across multiple therapeutic areas more efficiently and effectively. Huma’s data-driven platform makes identifying and prioritising at-risk patients easier, which improves patient safety, outcomes, and experience.

Our flexible, modular design allows you to manage multiple therapeutic area waiting lists with a single platform solution and secure additional outsourced clinician resources for face-to-face, virtual, and remote care. Huma enables multiple teams and specialists to review patient data and clinician notes on a unified dashboard for improved clinician collaboration.

About Huma

SAMD for Pharma

SAMD for Pharma

Discover Huma’s Platform

Huma’s platform can improve healthcare outcomes while helping to reduce the burden on the healthcare system. Discover how Huma’s award winning technology is making a difference in the lives of both patients and healthcare professionals.

Request a meeting

Huma is committed to respecting your privacy, and we’ll only use your personal details to provide information you have selected you’re interested in. Review our Privacy Policy for further information.

We’d love to send you our monthly newsletter about our latest work, research and events by email. We’ll always treat your personal details with the utmost care and will never sell them to other companies for marketing purposes.